-
1.
公开(公告)号:US07951950B2
公开(公告)日:2011-05-31
申请号:US11360885
申请日:2006-02-23
申请人: Jeremy D. Little , Shomir Ghosh , Sean Harrison , Amy M. Elder , Christelle C. Renou , Kenneth G. Carson
发明人: Jeremy D. Little , Shomir Ghosh , Sean Harrison , Amy M. Elder , Christelle C. Renou , Kenneth G. Carson
IPC分类号: C07D215/38
CPC分类号: C07D413/12 , C07D215/50 , C07D401/06 , C07D401/12 , C07D409/06 , C07D413/06 , C07D471/04 , C07D495/04
摘要: Disclosed are CRTH2 inhibitors represented by Structural Formula (I): The values for the variables of Structural Formula (I) are provided herein.
摘要翻译: 公开了由结构式(I)表示的CRTH2抑制剂:本文提供了结构式(I)的变量的值。
-
公开(公告)号:US07951801B2
公开(公告)日:2011-05-31
申请号:US11101998
申请日:2005-04-08
申请人: Michael E. Hepperle , Julie Fields Liu , Francois Soucy , Prakash Raman , Jeremy D. Little , Paul E. Fleming , Dominic Reynolds , Geraldine C. B. Harriman
发明人: Michael E. Hepperle , Julie Fields Liu , Francois Soucy , Prakash Raman , Jeremy D. Little , Paul E. Fleming , Dominic Reynolds , Geraldine C. B. Harriman
IPC分类号: A61K31/535 , C07D413/14
CPC分类号: C07D471/04
摘要: This invention provides beta-carboline compounds of formula III-A-aa: wherein Q, G, R1, R2, R3, and R6b are as described in the specification. The compounds are useful for treating diseases such as inflammatory diseases and cancer.
摘要翻译: 本发明提供式III-A-aa的β-咔啉化合物:其中Q,G,R 1,R 2,R 3和R 6b如说明书中所述。 该化合物可用于治疗疾病如炎性疾病和癌症。
-
3.
公开(公告)号:US20100093713A1
公开(公告)日:2010-04-15
申请号:US12640335
申请日:2009-12-17
申请人: Michael E. Hepperle , Julie Fields Liu , Francois Soucy , Yingchun Ye , Robert S. Murray , Raman Prakash , Jeremy D. Little , Alfredo Castro , Hormoz Mazdiyasni , Paul E. Fleming , Dominic Reynolds
发明人: Michael E. Hepperle , Julie Fields Liu , Francois Soucy , Yingchun Ye , Robert S. Murray , Raman Prakash , Jeremy D. Little , Alfredo Castro , Hormoz Mazdiyasni , Paul E. Fleming , Dominic Reynolds
IPC分类号: A61K31/541 , C07D471/04 , A61P35/04 , A61P37/00 , A61K31/5377 , A61P29/00 , A61K31/501 , A61K31/437 , C07D295/10
CPC分类号: C07D265/30 , C07D471/04
摘要: This invention provides beta-carboline compounds of formula wherein Ring A is a substituted pyridinyl, pyrimidinyl, morpholinyl, piperidinyl, piperazinyl, pyrrolidinyl, pyranyl, tetrahydrofuranyl, cyclohexyl, cyclopentyl or thiomorpholinyl ring and R1, R2 and R3 are as described in the specification. The compounds are IKK-2 inhibitors that are useful for treating IKK-2-mediated diseases such as inflammatory diseases and cancer.
摘要翻译: 本发明提供下式的β-咔啉化合物,其中环A是取代的吡啶基,嘧啶基,吗啉基,哌啶基,哌嗪基,吡咯烷基,吡喃基,四氢呋喃基,环己基,环戊基或硫代吗啉基,R1,R2和R3如说明书中所述。 这些化合物是可用于治疗IKK-2介导的疾病如炎性疾病和癌症的IKK-2抑制剂。
-
公开(公告)号:US07727985B2
公开(公告)日:2010-06-01
申请号:US10821545
申请日:2004-04-09
申请人: Michael E. Hepperle , Julie Fields Liu , Francois Soucy , Yingchun Ye , Robert S. Murray , Raman Prakash , Jeremy D. Little , Alfredo Castro , Hormoz Mazdiyasni , Paul E. Fleming , Dominic Reynolds
发明人: Michael E. Hepperle , Julie Fields Liu , Francois Soucy , Yingchun Ye , Robert S. Murray , Raman Prakash , Jeremy D. Little , Alfredo Castro , Hormoz Mazdiyasni , Paul E. Fleming , Dominic Reynolds
IPC分类号: A61K31/5377 , C07D413/14 , C07D413/02
CPC分类号: C07D265/30 , C07D471/04
摘要: This invention provides beta-carboline compounds of formula I: wherein Ring A is a substituted pyridinyl, pyrimidinyl, morpholinyl, piperidinyl, piperazinyl, pyrrolidinyl, pyranyl, tetrahydrofuranyl, cyclohexyl, cyclopentyl or thiomorpholinyl ring and R1, R2 and R3 are as described in the specification. The compounds are IKK-2 inhibitors that are useful for treating IKK-2-mediated diseases such as inflammatory diseases and cancer.
摘要翻译: 本发明提供式I的β-咔啉化合物:其中环A是取代的吡啶基,嘧啶基,吗啉基,哌啶基,哌嗪基,吡咯烷基,吡喃基,四氢呋喃基,环己基,环戊基或硫代吗啉基,R1,R2和R3如 规范。 这些化合物是可用于治疗IKK-2介导的疾病如炎性疾病和癌症的IKK-2抑制剂。
-
-
-